EUVIMEDEUVIMED entdecken
Scoping ReviewStudienprotokoll

Barriers and facilitators to designing, maintaining, and utilizing rare disease patient registries: a scoping review protocol

Catherine Stratton iD, Andrew Taylor, Menelaos Konstantinidis iD, Vanda McNiven, Peter Kannu, Peter Gill, Ian Stedman iD, Areti Angeliki Veroniki, Martin Offringa iD, Beth Potter iD, Durhane Wong-Rieger iD, John Adams und 12 weitere

JBI Evidence Synthesis · 2025

DOI: 10.11124/jbies-24-00091 ↗

Kurz gefasst

Scoping Review in der Zeitschrift JBI Evidence Synthesis, 2025. Verfasst von Catherine Stratton und 23 weiteren Autor:innen. Beteiligte Einrichtung: Li Ka Shing Knowledge Institute, St. Michael's Hospital, Unity Health Toronto, Toronto, ON, Canada. Hauptthemen laut MEDLINE: Rare Diseases, Registries. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 23 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

The objectives of this review are to identify barriers and facilitators to designing, maintaining, and utilizing rare disease patient registries; determine whether and how these differ among patient partners, other knowledge users, and researchers; and chart definitions of rare diseases and rare disease patient registries.

Introduction

Rare disease patient registries are vital to improving the understanding of the natural histories and predictors of outcomes of rare diseases, assessing interventions, and identifying potential participants for clinical trials. Currently, however, the functionality of rare disease patient registries is not fully optimized. To improve the quality and functionality of rare disease patient registries, it is important to understand the barriers and/or facilitators involved in their design, maintenance, and utilization; how these might differ among patient partners, other knowledge users, and researchers; and to delineate the range of definitions for rare diseases and rare disease patient registries. Inclusion criteria: Evidence from any study design or format (including empirical studies, books, manuals, commentaries, editorials, guidance documents, conference abstracts, review documents, and gray literature) that references barriers or facilitators for designing, maintaining, or utilizing rare disease patient registries will be considered for inclusion.

Methods

The review will follow the JBI methodology for scoping reviews. We will search health science databases, including the Cochrane Library, Embase, MEDLINE, the JBI EBP Database, and PsycINFO, from inception onwards. Multiple sources will be searched for theses and gray literature, including the Canadian Agency for Drugs and Technologies in Health (CADTH) Grey Matters. Two independent reviewers will screen titles and abstracts and full-text documents, as well as abstract data. Disagreements will be resolved through discussion or with a third reviewer. Evidence will be synthesized descriptively and reported using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews (PRIMSA-ScR). Review registration: Open Science Framework https://osf.io/mvf9r

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Rare DiseasesRegistriesHumansScoping Reviews as TopicResearch Design

Autor:innen und Institutionen

  • Li Ka Shing Knowledge Institute, St. Michael's Hospital, Unity Health Toronto, Toronto, ON, Canada.
  • Division of Epidemiology, Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada.
  • Drugs for Rare Diseases Directorate, Strategic Policy Branch, Health Canada, Ottawa, ON, Canada.
  • Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, ON, Canada.
  • Division of Genetics, Department of Pediatrics, McMaster University, Hamilton, ON, Canada.
  • Department of Medicine and Dentistry, University of Alberta, Edmonton, AB, Canada.

ORCID-Profile: Catherine Stratton, Menelaos Konstantinidis, Ian Stedman, Martin Offringa, Beth Potter, Durhane Wong-Rieger, Sarah Dyack, Pavel Zhelnov, Andrea C Tricco

Zitieren

APA

Stratton, C., Taylor, A., Konstantinidis, M., McNiven, V., Kannu, P., Gill, P., Stedman, I., Veroniki, A. A., Offringa, M., Potter, B., Wong-Rieger, D., Adams, J., Hodgkinson, K., Elliott, A. M., Neville, A., Faughnan, M., Dyack, S., Zhelnov, P., Daly-Cyr, J., …, & Tricco, A. C. (2025). Barriers and facilitators to designing, maintaining, and utilizing rare disease patient registries: a scoping review protocol. JBI Evidence Synthesis. https://doi.org/10.11124/jbies-24-00091

Vancouver

Stratton C, Taylor A, Konstantinidis M, McNiven V, Kannu P, Gill P, et al. Barriers and facilitators to designing, maintaining, and utilizing rare disease patient registries: a scoping review protocol. JBI Evidence Synthesis. 2025. doi:10.11124/jbies-24-00091

BibTeX
@article{Stratton2025,
  author = {Stratton, Catherine and Taylor, Andrew and Konstantinidis, Menelaos and McNiven, Vanda and Kannu, Peter and Gill, Peter and Stedman, Ian and Veroniki, Areti Angeliki and Offringa, Martin and Potter, Beth and Wong-Rieger, Durhane and Adams, John and Hodgkinson, Kathy and Elliott, Alison M and Neville, Alexandra and Faughnan, Marie and Dyack, Sarah and Zhelnov, Pavel and Daly-Cyr, Jennifer and McGowan, Jessie and Straus, Sharon and Smith, Maureen and Rosella, Laura and Tricco, Andrea C},
  title = {Barriers and facilitators to designing, maintaining, and utilizing rare disease patient registries: a scoping review protocol},
  journal = {JBI Evidence Synthesis},
  year = {2025},
  doi = {10.11124/jbies-24-00091}
}
Kostenlos starten →